Well, the dangerousness of cosmetics probably doesn't express itself in death/life statistics. The whitelisting model used in Europe is used to ensure that wha

Well, the dangerousness of cosmetics probably doesn't express itself in death/life statistics. The whitelisting model used in Europe is used to ensure that whatever substance causes the least amount of issues possible if released. You know, interactions with skin conditions, maybe breathing complications if inhaled etc. The basic tradeoff here is potential (minor or not) health hazard vs. profit opportunities of companies. Characteristically the EU chooses the first and the US the second.